Proteomics International (ASX:PIQ) pursues FDA approval for PromarkerD – The Market Herald

“Proteomics expects to meet with the FDA to progress its clearance within 10 weeks. If PromarkerD gains FDA approval, the company will be able to deploy its easy-to-use, inexpensive blood test throughout the United States.”

Article: Proteomics International (ASX:PIQ) pursues FDA approval for PromarkerD